Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 20Other hematologic neoplasm 13Gynecologic 4Plasma cell 2Dermatologic 2Sarcoma 1Myeloid 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 51Endometrial Neoplasms 21Fallopian Tube Neoplasms 17Sarcoma 9Peritoneal Neoplasms 9Neoplasm Metastasis 7Neoplasms 6Liposarcoma 6Leiomyosarcoma 5Hemangiosarcoma 5Fibrosarcoma 5Carcinoma, Ovarian Epithelial 5Uterine Neoplasms 4Stomach Neoplasms 4Sarcoma, Synovial 4Recurrence 4Neurofibrosarcoma 4Malignant mesenchymal tumor 4Histiocytoma, Malignant Fibrous 4Desmoplastic Small Round Cell Tumor 4Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma, Endometrial Stromal 3Rhabdomyosarcoma 3Hemangiopericytoma, Malignant 3Breast Neoplasms 3Appendiceal Neoplasms 3Sarcoma, Alveolar Soft Part 2Pheochromocytoma 2

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Gemcitabine 7Cyclophosphamide 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recurrence × Doxorubicin × Gynecologic × Clear all
NCT01809379 2022-07-08

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Ruhr University of Bochum

Phase 2 Completed
69 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

NCT02475772 2022-07-08

A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis

Ruhr University of Bochum

Phase 1 Completed
15 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

NCT00262990 2020-12-17

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Novartis

Phase 3 Completed
829 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence

NCT02107378 2016-11-30

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

Sotio Biotech Inc.

Phase 2 Terminated
22 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡